Davita Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $212.87 (market cap $39.15B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 3.5× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 110 Days on average.
| DVA | TTWO | |
|---|---|---|
Market Cap | $11.29B | $39.15B |
Volume | 582,204 | 2,708,429 |
Sector | Health | Technology |
52-Week High | $240.96 | $262.29 |
52-Week Low | $103.87 | $189.69 |
Typical Hold Time | 113 Days | 110 Days |
Enterprise Value | $24.01B | $40.27B |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
Take-Two Interactive trades at $204.01, up 0.73% with mixed technical signals showing bearish moving averages but neutral oscillators. The company faces fundamental challenges with a net loss of -$4.48 billion in 2025 and negative profit margins, though revenue grew to $5.63 billion. Recent news highlights GTA VI's confirmed November 2026 launch date as a potential catalyst, while institutional buying and strong analyst support (79% buy ratings) suggest long-term confidence despite current profitability issues.
The outlook hinges on GTA VI's successful execution, with analyst consensus target at $292.30 representing 43% upside. Key risks include persistent negative cash flow from operations, high debt levels, and execution challenges in the competitive gaming sector. The stock offers substantial potential upside if management can translate strong franchises into sustainable profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →